The effect of pentoxifylline on existing hypersensitivity in a rat model of neuropathy

Anesth Analg. 2008 Feb;106(2):650-3, table of contents. doi: 10.1213/ane.0b013e31815efaba.

Abstract

Background: Using a rat L5 spinal nerve transection model we previously showed that pentoxifylline prevents hyperalgesia through antiinflammation in the prefrontal brain. In this study, we examined efficacy when applied after injury.

Methods: We examined the effect of pentoxifylline on existing mechanical allodynia, observing glial activation and proinflammatory cytokine expression in the lumbar spinal cord, when given 7 days after L5 spinal nerve transection.

Results: There was no effect from pentoxifylline on existing hypersensitivity, glial activation, and cytokine expression when applied after L5 spinal nerve transection.

Conclusion: Pentoxifylline administered intraperitoneally on day 7 postsurgery failed to alleviate existing hypersensitivity, or reduce glial activation and cytokine expression.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal*
  • Hyperalgesia / drug therapy*
  • Hyperalgesia / physiopathology
  • Male
  • Nervous System Diseases / drug therapy*
  • Nervous System Diseases / physiopathology
  • Pain / drug therapy
  • Pain / physiopathology
  • Pentoxifylline / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Pentoxifylline